| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/15/2004 | US20040009588 Comprises targeted adenoviral expression vector coding antitumor agent; gene therapy; gene expression inhibition |
| 01/15/2004 | US20040009566 Cultured myocardial cell sheet which retains contracting and relaxing functions for diagnosing and treating cardiovascular, digestive and circulatory organ disorders; animal models |
| 01/15/2004 | US20040009551 Comprises nucleotide sequences coding peptide antibiotic for treatment of parasitic infection and cell proliferative disorders |
| 01/15/2004 | US20040009505 A pair of genetic engineered primers for the mutagenic amplification, therapeutic treatment |
| 01/15/2004 | US20040009233 Shark meat extract |
| 01/15/2004 | US20040009187 Rotavirus subunit vaccine |
| 01/15/2004 | US20040009185 Enhancing the immune response to an antigen by presensitzing with an inducing agent prior to immunizing with the agent and the antigen |
| 01/15/2004 | US20040009180 Transdermal botulinum toxin compositions |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | US20040009160 Bioactive food complex, method for making bioactive food complex product and method for controlling disease |
| 01/15/2004 | US20040009157 Methods of inducing or enhancing cartilage repair |
| 01/15/2004 | US20040009155 Method for sustaining direct cell delivery |
| 01/15/2004 | US20040009123 Methylenediphosphonate derivatives containing one or two hydroxy groups, useful for treating parasitosis and autoimmune maldy in primate |
| 01/15/2004 | US20040007540 Selective deleukocytation unit for a platelet product |
| 01/15/2004 | CA2527619A1 Osteoinductive biomaterials |
| 01/15/2004 | CA2491907A1 Oncolytic virus replicating selectively in tumor cells |
| 01/15/2004 | CA2491710A1 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 01/15/2004 | CA2491513A1 Compositions and methods for ligament growth and repair |
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1379994A2 Extracorporeal blood processing information management system |
| 01/14/2004 | EP1379869A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379670A1 Activated dual specificity lymphocytes and their methods of use |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379650A2 Preferred segments of neural thread protein and methods of using the same |
| 01/14/2004 | EP1379640A1 Monochromatic fluid treatment systems |
| 01/14/2004 | EP1379635A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 01/14/2004 | EP1379627A1 Method for differentiating mesenchymal stem cells into neural cells |
| 01/14/2004 | EP1379626A2 A method for differentiating stem cells into insulin-producing cells |
| 01/14/2004 | EP1379625A1 Cd4+cd25+ regulatory t cells from human blood |
| 01/14/2004 | EP1379624A2 Transfection of human embryonic stem cells |
| 01/14/2004 | EP1379535A2 Expression vectors able to elicit improved immune response and methods of using same |
| 01/14/2004 | EP1379282A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 01/14/2004 | EP1379278A2 Method of inducing proliferation of retinal stem cells |
| 01/14/2004 | EP1379268A1 Chondrogenic potential of human bone marrow-derived cd105?+ cells by bmp |
| 01/14/2004 | EP1379264A1 Human secreted proteins |
| 01/14/2004 | EP1379260A2 Methods for treating the inflammatory component of a brain disorder |
| 01/14/2004 | EP1379223A1 Dental formulation |
| 01/14/2004 | EP1379140A2 Production of pancreatic islet cells and delivery of insulin |
| 01/14/2004 | EP1379139A2 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 01/14/2004 | EP1379133A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 01/14/2004 | EP1379132A2 Human secreted proteins |
| 01/14/2004 | EP0690991B2 Novel anticoagulant cofactor activity |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468302A Gsk3 polypeptides |
| 01/14/2004 | CN1468108A Bone health compositions derived from milk |
| 01/14/2004 | CN1468105A Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 01/14/2004 | CN1468089A Microparticles for delivery of the heterologous nucleic acids |
| 01/14/2004 | CN1467290A Lactob.plantarum ST-III strain and application in regulating blood fat |
| 01/14/2004 | CN1467289A Method for extracting microorganism producing biological active substance from sponge cell |
| 01/14/2004 | CN1467248A Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 01/14/2004 | CN1466988A Chinese materia medica preparation for treating burn and scald and method for preparing the same |
| 01/14/2004 | CN1466987A Medicine for preventing SARS and influenza-propolis lozenge and complement synergy medicine |
| 01/14/2004 | CN1466979A Chinese patent drug for preventing miscarriage and promoting health growth of fetus and process for preparing the same |
| 01/14/2004 | CN1466978A Chinese traditional medicine for treating cerebral thrombus and method for preparing the same |
| 01/14/2004 | CN1466976A Medicine for preventing and curing rachitis and osteoporosis and method for preparing the same |
| 01/14/2004 | CN1466955A Composite biological active capsule and method for preparing the same |
| 01/14/2004 | CN1466954A Pilose antler composition and method for preparing the same |
| 01/14/2004 | CN1134537C Preparation of human primitive mesenchymal stem cell population |
| 01/14/2004 | CN1134451C Inhibitor of collagen-stimulated platelet aggregation |
| 01/14/2004 | CN1134266C Methods for inducing T cell tolerance to tissue or organ graft |
| 01/14/2004 | CN1134261C Quick-acting beriberi powder |
| 01/14/2004 | CN1134214C Method of biological control |
| 01/13/2004 | US6677433 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins |
| 01/13/2004 | US6677370 Stabilizing microtubules and preventing depolymerization; antiproliferative, anticarcinogenic and antiinflammatory agents; autoimmune diseases |
| 01/13/2004 | US6677127 Nucleic acid respiratory syncytial virus vaccines |
| 01/13/2004 | US6676958 Adjuvant composition for mucosal and injection delivered vaccines |
| 01/13/2004 | US6676949 Two-step immunization procedure against Chlamydia infection |
| 01/13/2004 | US6676945 Induction immunology response |
| 01/13/2004 | US6676938 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 01/13/2004 | US6676935 Transfection target cells; genetic engineering |
| 01/13/2004 | US6676924 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 01/13/2004 | US6676675 Patterned substrates and methods for nerve regeneration |
| 01/13/2004 | CA2063790C Biological fluid processing |
| 01/13/2004 | CA2000498C Osteogenic factors |
| 01/10/2004 | CA2434951A1 A selective deleukocytation unit for a platelet product |
| 01/08/2004 | WO2004003562A2 Oncolytic viruses as phenotyping agents for neoplasms |
| 01/08/2004 | WO2004003235A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | WO2004003215A1 Method of isolating biologically active fraction containing clinically acceptable native slipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides |
| 01/08/2004 | WO2004003209A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | WO2004003185A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 01/08/2004 | WO2004003184A1 A method for obtaining purified bacteriophage preparation s |
| 01/08/2004 | WO2004003182A2 Homozygous stem cells isolated from pathogenic oocytes |
| 01/08/2004 | WO2004003181A2 Method for preparing animal or human adult stem cells and therapeutic use thereof |
| 01/08/2004 | WO2004003178A2 Decellularized tissue |
| 01/08/2004 | WO2004003164A2 Methods of organ regeneration |
| 01/08/2004 | WO2004003142A2 Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 01/08/2004 | WO2004003130A1 Chitosan/acidic biopolymer hybrid fiber and culture base for animal cells |
| 01/08/2004 | WO2004002527A1 Compositions against chicken coccidiosis |
| 01/08/2004 | WO2004002502A1 Botulinum toxins for treating priapism |
| 01/08/2004 | WO2004002501A1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 01/08/2004 | WO2004002500A1 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 01/08/2004 | WO2004002421A2 Method for the treatment of multiple sclerosis |
| 01/08/2004 | WO2004002412A2 A method and composition to elicit an effective autologous antitumoral immune response in a patient |
| 01/08/2004 | WO2004002367A1 Drug eluting stent |
| 01/08/2004 | WO2003093455A3 Adenovirus vectors for immunotherapy |
| 01/08/2004 | WO2003092579A3 Compositions and methods for treating cancer with an oncolytic viral agent |
| 01/08/2004 | WO2003091387A3 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 01/08/2004 | WO2003085092A3 Cellular transplantation for heart regeneration |
| 01/08/2004 | WO2003068149A3 Preparations of nucleus pulposus cells and methods for their generation, identification, and use |